These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 23462208)
1. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Mathew M; Tam M; Ott PA; Pavlick AC; Rush SC; Donahue BR; Golfinos JG; Parker EC; Huang PP; Narayana A Melanoma Res; 2013 Jun; 23(3):191-5. PubMed ID: 23462208 [TBL] [Abstract][Full Text] [Related]
2. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity. Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225 [TBL] [Abstract][Full Text] [Related]
3. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases. Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482 [TBL] [Abstract][Full Text] [Related]
4. Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases. Patel KR; Shoukat S; Oliver DE; Chowdhary M; Rizzo M; Lawson DH; Khosa F; Liu Y; Khan MK Am J Clin Oncol; 2017 Oct; 40(5):444-450. PubMed ID: 26017484 [TBL] [Abstract][Full Text] [Related]
5. The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab. Cohen-Inbar O; Shih HH; Xu Z; Schlesinger D; Sheehan JP J Neurosurg; 2017 Nov; 127(5):1007-1014. PubMed ID: 28059663 [TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment. Kiess AP; Wolchok JD; Barker CA; Postow MA; Tabar V; Huse JT; Chan TA; Yamada Y; Beal K Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):368-75. PubMed ID: 25754629 [TBL] [Abstract][Full Text] [Related]
7. Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery. Tazi K; Hathaway A; Chiuzan C; Shirai K Cancer Med; 2015 Jan; 4(1):1-6. PubMed ID: 25164960 [TBL] [Abstract][Full Text] [Related]
8. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma. Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071 [TBL] [Abstract][Full Text] [Related]
9. Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series. Jones PS; Cahill DP; Brastianos PK; Flaherty KT; Curry WT Neurosurg Focus; 2015 Mar; 38(3):E5. PubMed ID: 25727227 [TBL] [Abstract][Full Text] [Related]
10. Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment. Ly D; Bagshaw HP; Anker CJ; Tward JD; Grossmann KF; Jensen RL; Shrieve DC J Neurosurg; 2015 Aug; 123(2):395-401. PubMed ID: 25768829 [TBL] [Abstract][Full Text] [Related]
11. LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases. Ahmed KA; Freilich JM; Sloot S; Figura N; Gibney GT; Weber JS; Sarangkasiri S; Chinnaiyan P; Forsyth PA; Etame AB; Rao NG J Neurooncol; 2015 Mar; 122(1):121-6. PubMed ID: 25519302 [TBL] [Abstract][Full Text] [Related]